We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Microfluidics: Emerging Prospects for Anti-Cancer Drug Screening

News   Sep 21, 2011

 
Microfluidics: Emerging Prospects for Anti-Cancer Drug Screening
 
 
Advertisement
 

RELATED ARTICLES

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

Team Screens Millions of Active Substances Against SARS-CoV-2

News

Researchers are screening millions of molecules in order to find those blocking interactions on SARS-CoV-2, to identify those that can be used therapeutically.

READ MORE

Human Cell “Membrane-on-Chip'” Helps Hunt for Drugs Against COVID-19

News

Researchers have created a human cell '"membrane on a chip" that allows continuous monitoring of how drugs and infectious agents interact with our cells. The device could soon be used to screen potential drug candidates against SARS-CoV-2.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE